Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse

Journal of the American College of Cardiology

Volumn 24, Issue 4, 1994, Pages 880-885

  Maron, Barry J ^a   Isner, Jeffrey M ^a   McKenna, William J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; CONFERENCE PAPER; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MITRAL VALVE PROLAPSE; MYOCARDITIS; PERICARDIAL DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SPORT; MYOCARDIAL DISEASE; ORGANIZATION AND MANAGEMENT; PERICARDITIS; RISK; SPORTS MEDICINE;

CARDIOMYOPATHY, HYPERTROPHIC; ELIGIBILITY DETERMINATION; HUMAN; MITRAL VALVE PROLAPSE; MYOCARDIAL DISEASES; MYOCARDITIS; PERICARDITIS; RISK; SPORTS; SPORTS MEDICINE;

EID: 0028065440     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(94)90844-3     Document Type: Article

References (91)

1. How common is hypertrophic cardiomyopathy?: Echocardiographically identified prevalence in a general population of young adults (The CARDIA Study) [abstract]
2. Idiopathic hypertrophic subaortic stenosis: I. A description of the disease based upon an analysis of 64 patients
3. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk
4. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients
5. Sudden death in young athletes
6. Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy. A review
7. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy
8. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy
9. Cardiac pathology and sports medicine
10. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy
11. Sudden cardiac death in hypertrophic cardiomyopathy
12. Idiopathic hypertrophic subaortic stenosis in the young
13. Cardiovascular causes of “athletic field” deaths: analysis of sudden death in 84 competitive athletes [abstract]
14. Hypertrophic cardiomyopathy: a discussion of nomenclature
15. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide-angle, two dimensional echocardiographic study of 125 patients
16. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy
17. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study
18. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy
19. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis
20. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients
21. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance
22. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy
23. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography
24. Familial hypertrophic cardiomyopathy is a genetically heterogenous disease
25. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere
26. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
27. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes
28. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes
29. Structural features of the athlete heart as defined by echocardiography
30. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes
31. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing “athlete's heart” from hypertrophic cardiomyopathy
32. Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass
33. Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass
34. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy
35. Surviving competitive athletics with hypertrophic cardiomyopathy
36. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features
37. Arrhythmia in hypertrophic cardiomyopathy. I: influence on prognosis
38. Prognostic significance of 24-hour ambulatory ectrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study
39. Myocardial infarctions: special considerations
40. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
41. Programmed electrical stimulation in hypertrophic cardiomyopathy results in patients with and without cardiac arrest or syncope
42. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: a consecutive analysis in 155 patients
43. Value of programmed electrical stimulation using a standardized ventricular stimulation protocol in hypertrophic cardiomyopathy
44. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death
45. Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings
46. Electrophysiologic studies of patients with hypertrophic cardiomyopathy presenting with syncope of undetermined etiology
47. Arrhythmias in hypertrophic cardiomyopathy
48. The cardiomyopathies mortality sudden death and ventricular arrhythmias
49. Syncope in hypertrophic cardiomyopathy multivariate analysis of prognostic determinants
50. Clinical significance and therapeutic implications of the left ventricular outflow tract pressure gradient in hypertrophic cardiomyopathy
51. Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient
52. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patents with hypertrophic cardiomyopathy
53. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy
54. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study
55. The mitral valve prolapse enigma-two decades later
56. The click-murmur syndrome: a clinical problem in diagnosis and treatment
57. Clinical spectrum and long-term follow-up of isolated mitral valve prolapse in 119 children
58. Late systolic murmurs and non-ejection (“mid-late”) systolic clacks: an analysis of 90 patients
59. Mitral valve prolapse and the mitral valve prolapse syndrome: a diagnostic classification and pathogenesis of symptoms
60. Orthostatic hypotension: a commonly unrecognized cause of symptoms in mitral valve prolapse
61. Echocardiographicaily documented mitral-valve prolapse: long-term follow-up of 237 patients
62. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse
63. Comparison of cardiac findings in patients with mitral valve prolapse who die suddenly to those who have congestive heart failure from mitral regurgitation and to those with fatal noncardiac conditions
64. The myxomatous mitral valve and sudden death
65. Sudden death in the mitral valve prolapse-click syndrome
66. Morphologic comparison of patients with mitral valve prolapse who died suddenly with patients who died from severe valvular dysfunction or other conditions
67. Ventricular buckling: a factor in the abnormal ventriculogram and peculiar hemodynamics associated with mitral valve prolapse
68. Sudden death in three teenagers: conduction system studies
69. Sudden death in primary mitral valve prolapse
70. Maladies attributed to myxomatous mitral valve
71. Pathologic features of sudden death in children, adolescents and young adults
72. The conduction system in mitral valve prolapse syndrome with sudden death
73. Ballooning deformity (mucoid degeneration) of atrioventricular valves
74. Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography
75. The natural history of idiopathic dilated cardiomyopathy
76. Myocarditis: a histopathologic definition and classification
77. Sudden cardiac death in Air Force recruits: a 20-year review
78. Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer
79. Isolated myocardial fibrosis as a cause of sudden cardiac death and its possible relation to myocarditis
80. Acute cardiac events temporally related to cocaine abuse
81. The effects of acute and chronic cocaine use on the heart
82. Cocaine and the heart
83. Cardiovascular effects of cocaine: an autopsy study of 40 patients
84. Cocaine-induced coronary artery vasoconstriction
85. The cardiovascular manifestations of the hypereosinophilic syndrome: prospective study of 26 patients, with review of the literature
86. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II)
87. Right ventricular cardiomyopathy and sudden death in young people
88. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases
89. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy